<DOC>
	<DOCNO>NCT02396394</DOCNO>
	<brief_summary>WiseMama design improve understand intervention feasible effective help HIV-positive pregnant postpartum woman maintain high adherence antiretroviral medication . The study involve : ) assess feasibility acceptability use innovative pill container equip real-time electronic data monitoring capacity HIV positive pregnant postpartum woman Uganda ; b ) generate preliminary effectiveness data 2-step feedback intervention retention care , antiretroviral therapy adherence , clinical outcome ( CD4 HIV viral load ( VL ) ) ; c ) explore patient provider perspectives barrier facilitator retention care adherence antiretroviral therapy study population .</brief_summary>
	<brief_title>Improving ART Retention Adherence Uganda : The WiseMama Study</brief_title>
	<detailed_description>The investigator implement WiseMama 2.5 year use randomize controlled trial design assess 2-step feedback intervention . Researchers also investigate barrier facilitator retention care antiretroviral therapy adherence use quantitative qualitative research method . 130 pregnant woman enrol two ( three need ) clinic sit Uganda `` Option B+ '' standard care . HIV-positive pregnant woman enrol study randomize either intervention comparison group approximately 6-month intervention . The study follow woman additional 3 month determine potential sustainability impact intervention . In addition adherence clinical data , quantitative qualitative data collect use survey instrument , focus group , in-depth interview . Analysis data enable achievement specific aim contribute scientific evidence base effective approach promote antiretroviral therapy adherence among pregnant postpartum HIV positive woman Uganda similar population low-resource setting . The specific aim study : 1 . Test acceptability feasibility use electronic pill container pregnant postpartum woman . Acceptability feasibility device among pregnant postpartum woman Uganda implementation randomize control trial ( RCT , see specific aim 2 ) . 2 . Evaluate preliminary effectiveness 2-step feedback retention care ART adherence , clinical outcome pregnant postpartum woman . We evaluate preliminary effectiveness intervention conduct RCT . 3 . Explore patient provider perspectives barrier facilitator retention care adherence ART . We use mixed method research approach collect data pregnant postpartum woman , health care provider , counselor elicit in-depth information regard behavioral , health systems-related , community , social factor influence adherence retention care .</detailed_description>
	<criteria>HIV positive pregnant woman Who 18 year age Who receive antenatal care , ARTnaive , initiate ART one study sit Central Uganda Pregnant woman must 18 26 week estimate gestation Be able use cell phone receive text message Provide write informed consent . Women previous experience ARV medication , receive text message home , unwilling provide write informed consent allow participate</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>HIV</keyword>
	<keyword>ART Adherence</keyword>
	<keyword>Retention Care</keyword>
	<keyword>Pregnant Women</keyword>
	<keyword>Postpartum Women</keyword>
</DOC>